ATE149350T1 - Verwendung des l-deprenyls zur verzögerung der altersbedingten zerstörung des gedächtnis bei hunden - Google Patents

Verwendung des l-deprenyls zur verzögerung der altersbedingten zerstörung des gedächtnis bei hunden

Info

Publication number
ATE149350T1
ATE149350T1 AT91302820T AT91302820T ATE149350T1 AT E149350 T1 ATE149350 T1 AT E149350T1 AT 91302820 T AT91302820 T AT 91302820T AT 91302820 T AT91302820 T AT 91302820T AT E149350 T1 ATE149350 T1 AT E149350T1
Authority
AT
Austria
Prior art keywords
deprenyl
dogs
related memory
memory destruction
delay age
Prior art date
Application number
AT91302820T
Other languages
English (en)
Inventor
Norton W Milgram
David R Stevens
Gwendolyn O Ivy
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE149350(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of ATE149350T1 publication Critical patent/ATE149350T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
AT91302820T 1990-08-31 1991-03-28 Verwendung des l-deprenyls zur verzögerung der altersbedingten zerstörung des gedächtnis bei hunden ATE149350T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (1)

Publication Number Publication Date
ATE149350T1 true ATE149350T1 (de) 1997-03-15

Family

ID=27076843

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96103701T ATE181501T1 (de) 1990-08-31 1991-03-28 Verwendung von l-deprenyl zur hemmung des alterniedergangs des immunsystems in säugetieren
AT91302820T ATE149350T1 (de) 1990-08-31 1991-03-28 Verwendung des l-deprenyls zur verzögerung der altersbedingten zerstörung des gedächtnis bei hunden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96103701T ATE181501T1 (de) 1990-08-31 1991-03-28 Verwendung von l-deprenyl zur hemmung des alterniedergangs des immunsystems in säugetieren

Country Status (16)

Country Link
US (2) US5276057A (de)
EP (2) EP0473252B1 (de)
JP (3) JP2819072B2 (de)
AT (2) ATE181501T1 (de)
AU (1) AU633714B2 (de)
BR (1) BR9103506A (de)
CA (1) CA2039194C (de)
DE (2) DE69124875T2 (de)
DK (2) DK0473252T3 (de)
ES (2) ES2135123T3 (de)
GR (2) GR3022971T3 (de)
HK (1) HK1011611A1 (de)
ID (1) ID19492A (de)
MX (1) MX9100067A (de)
MY (2) MY124210A (de)
NZ (1) NZ238277A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (de) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Verwendung von deprenyl zur unterhaltung,verhinderung von verlust oder zurückgewinnung von nervenzellefunktion
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
US5547995B1 (en) * 1993-05-04 1998-01-27 Sanofi Elf Use of selegiline in veterinary medicine
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
CN100360123C (zh) 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
WO1996024346A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH11506744A (ja) 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク． 室温で液体である低分子量薬を含む経皮組成物
ES2180809T5 (es) * 1995-11-06 2005-06-16 Somerset Pharmaceuticals, Inc. Administracion de selegilina sublingual y bucal.
IL138290A0 (en) 1998-03-16 2001-10-31 Somerset Pharmaceuticals Inc Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
WO2004041151A2 (en) * 2002-11-07 2004-05-21 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
US20050009862A1 (en) * 2003-04-25 2005-01-13 Sabounjian Luann Method for promoting uninterrupted sleep by administration of trospium chloride
EP1686973A4 (de) * 2003-11-25 2009-03-25 Technion Res & Dev Foundation Zusammensetzungen und verfahren zur behandlung von kardiovaskulären erkrankungen und krankheiten
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
CA2785642C (en) 2009-12-29 2014-12-02 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
SG183150A1 (en) 2010-02-03 2012-09-27 Pharma Two B Ltd Extended release formulations of rasagiline and uses thereof
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
GR3031263T3 (en) 1999-12-31
JP2884501B2 (ja) 1999-04-19
MX9100067A (es) 1992-04-01
DE69131386T2 (de) 1999-11-25
CA2039194A1 (en) 1992-03-01
NZ238277A (en) 1993-10-26
MY110217A (en) 1998-03-31
BR9103506A (pt) 1992-05-12
AU7395791A (en) 1992-03-05
US5387615A (en) 1995-02-07
DE69124875D1 (de) 1997-04-10
JP2884500B2 (ja) 1999-04-19
EP0473252A3 (en) 1992-08-05
HK1011611A1 (en) 1999-07-16
DE69131386D1 (de) 1999-07-29
CA2039194C (en) 1997-01-28
EP0732101B1 (de) 1999-06-23
DK0473252T3 (da) 1997-09-15
AU633714B2 (en) 1993-02-04
MY124210A (en) 2006-06-30
ES2135123T3 (es) 1999-10-16
ID19492A (id) 1998-07-16
JPH04230624A (ja) 1992-08-19
JPH09328422A (ja) 1997-12-22
EP0473252A2 (de) 1992-03-04
JPH09328423A (ja) 1997-12-22
EP0732101A1 (de) 1996-09-18
US5276057A (en) 1994-01-04
ATE181501T1 (de) 1999-07-15
ES2097790T3 (es) 1997-04-16
JP2819072B2 (ja) 1998-10-30
DK0732101T3 (da) 1999-11-22
EP0473252B1 (de) 1997-03-05
DE69124875T2 (de) 1997-06-26
GR3022971T3 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
ATE149350T1 (de) Verwendung des l-deprenyls zur verzögerung der altersbedingten zerstörung des gedächtnis bei hunden
LV10918A (lv) Azitromicina pielietosanas panemiens
KR930702519A (ko) 동물 및 사람에서의 감염을 치료 및 예방하는 신규한 항체
SE503436C2 (sv) Pyroglutamidderivat
DE3881533T2 (de) Tiermedizinische zusammensetzung zur verhinderung von diarrhoe bei tieren.
DE3851456T2 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
DE68909465D1 (de) Behandlung von pferdeviehbestand.
FI881420A (fi) Voimalaitos, jossa palaminen tapahtuu leijukerroksessa
DE59103571D1 (de) Synergistische Mittel zur Regulierung des Pflanzenwachstums.
DE69207898T2 (de) Wirkstoff zur hautbehandlung bei tieren
ES556049A0 (es) Instalacion para la cria de conejos y de animales similares
BR6602122U (pt) Ferradura amortecedora e antiderrapante para cavalos
KR890015797U (ko) 사육동물 분만용 산실기
RU96107604A (ru) Средство для повышения роста и сохранности ягнят
NO871971D0 (no) Anordning for kontroll av foring i fiskeoppdrettsanlegg.
ES294387Y (es) Herradura de caucho para caballerias
ITRA910008V0 (it) Distributopre semovente di mangime, pellettato di sfuso, per l'ali- mentazione di animali in batteria
DE69203723D1 (de) Verfahren zur Erhöhung der Zucht von Vieh.
ITVR920064V0 (it) Alveare autobloccante

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee